What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Message Boards Settings Enzo Biochem, Inc. (ENZ) - Quote Info
treatment of non-alcoholic steatohepatitis.      4-Nov-09 07:44 am    
Enzo Biochem Inc. (NYSE:ENZ) announced today that they have favorable results of the Company’s clinical trial for the treatment of non-alcoholic steatohepatitis. The information was presented by Enzo Biochem at the annual meeting of the American Association for the Study of Liver Diseases. http://www.favstocks.com/enzo-biochem-na...
Currently, the causes of NASH are not well-defined due to which there is currently no medical therapy available in the market to combat NASH.
Rating :
 (No ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

sarun82@roc...

24/Male
Pondicherry...


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
treatment of non-alcoholic steatohepatitis.
sarun82@roc... Not rated 4-Nov-09 07:44 am  
 
Give me a break. Is this what you do all day long....
lymezhome 4-Nov-09 09:26 pm  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Enzo Biochem Inc. (ENZ)

Chart for Enzo Biochem Inc. (ENZ)
At 12:09PM ET: 5.58 Up 0.01 (0.18%)
Symbol Lookup